Truvestments Capital’s DexCom DXCM Stock Holding History

Truvestments Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.26K	Hold	20	–	–	﹤0.01%	1035
2025 Q4	$1.33K	Hold	20	–	–	﹤0.01%	908
2025 Q3	$1.35K	Hold	20	–	–	﹤0.01%	943
2025 Q2	$1.75K	Sell	20 -100	-83%	-$7.84K	﹤0.01%	856
2025 Q1	$8.2K	Hold	120	–	–	﹤0.01%	684
2024 Q4	$9.33K	Sell	120 -24	-17%	-$1.78K	﹤0.01%	619
2024 Q3	$9.65K	Buy	+144	New	+$11.8K	﹤0.01%	588
2024 Q1	–	Sell	-40	Closed	-$4.96K	–	765
2023 Q4	$4.96K	Hold	40	–	–	﹤0.01%	597
2023 Q3	$3.73K	Hold	40	–	–	﹤0.01%	539
2023 Q2	$5.14K	Hold	40	–	–	﹤0.01%	524
2023 Q1	$4.65K	Buy	+40	New	+$4.48K	﹤0.01%	520

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Truvestments Capital's DXCM Position: Q1 2026 in Review

Truvestments Capital held its DexCom (DXCM) position steady in Q1 2026 at 20 shares worth $1.26K. The position accounts for ﹤0.01% of the portfolio, ranked #1035.

Truvestments Capital first reported a position in DXCM in Q1 2023 and has held it in 11 quarters since. The position peaked at $9.65K in Q3 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Truvestments Capital held 20 shares of DexCom worth $1.26K as of Q1 2026.
Truvestments Capital left its DexCom share count unchanged in Q1 2026.
DexCom made up ﹤0.01% of Truvestments Capital's portfolio in Q1 2026, its #1035 holding.
Truvestments Capital first reported a position in DexCom in Q1 2023 and has held it in 11 quarters since.
Truvestments Capital's DexCom position peaked at $9.65K in Q3 2024.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Truvestments Capital's 13F filing for Q1 2026, filed 13 May 2026.